Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 991-1000 of 2916 for cancer

Edit search filters
  1. CBT Based Pain Management Program For The Treatment Of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) In Breast Cancer Survivors

    Jacksonville, FL

  2. A Study Of AL101 In Patients With Adenoid Cystic Carcinoma Bearing Activating Notch Mutations

    Rochester, MN

  3. Botulinum Toxin A (Botox) In Tissue Expander Breast Reconstruction

    Rochester, MN

  4. Analyses Of Metabolic Agents Following Brain Radiation

    Rochester, MN

  5. Open-Label Study Of The CDK4/6 Inhibitor SPH4336 In Subjects With Locally Advanced Or Metastatic Liposarcomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. Study Of Lurbinectedin In Combination With Doxorubicin Versus Doxorubicin Alone As First-line Treatment In Participants With Metastatic Leiomyosarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate The Safety Of Lasofoxifene In Combination With Abemaciclib In Advanced Or Metastatic ER+/HER2− Breast Cancer With ESR1 Mutation

    Jacksonville, FL, Rochester, MN

  8. PKCι & MTOR Inhibition With Auranofin+Sirolimus For Squamous Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. A Study To Investigate Efficacy & Safety Of Intratumoral INT230-6 Compared To US Standard Of Care In Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Evaluate The Safety, Tolerance And Anti-tumor Activity Of SAR442257 In Patients With Relapsed/Refractory Multiple Myeloma And Relapsed/Refractory Non-Hodgkin Lymphoma

    Rochester, MN

.

Mayo Clinic Footer